| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/02/2009 | EP2094733A1 Fgfr4 antibodies |
| 09/02/2009 | EP2094730A2 Methods and materials related to anti-amyloid antibodies |
| 09/02/2009 | EP2094729A1 Abeta antibody parenteral formulation |
| 09/02/2009 | EP2094724A1 Protein composition for inducing an immune response in a vertebrate comprising a plurality of protein variants covering the heterogeneity of a single antigen, ama1 |
| 09/02/2009 | EP2094307A2 Tes7 and antibodies that bind thereto |
| 09/02/2009 | EP2094306A2 Treatment of il-1-beta related diseases |
| 09/02/2009 | EP2094305A2 Method for treating pathological pulmonary conditions and bleomycin associated pulmonary fibrosis |
| 09/02/2009 | EP2094304A1 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 09/02/2009 | EP2094303A1 Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof |
| 09/02/2009 | EP2094302A2 Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity |
| 09/02/2009 | EP2094301A1 Poxviridae treatment comprising tap-1 and/or tap-2 as a molecular adjuvant |
| 09/02/2009 | EP2094300A1 Medicinal formulation for the treatment for hepatitis c |
| 09/02/2009 | EP2094299A1 Recombinant modified vaccinia virus ankara (mva)-based vaccine for the avian flu |
| 09/02/2009 | EP2094298A2 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 09/02/2009 | EP2094297A2 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 09/02/2009 | EP2094296A2 Multicomponent vaccine |
| 09/02/2009 | EP2094295A2 Method for the diagnosis and/or monitoring of invasive aspergillosis |
| 09/02/2009 | EP2094294A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 09/02/2009 | EP2094293A1 Tissue targeted antigenic activation of the immune response to treat cancers |
| 09/02/2009 | EP2094282A2 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 09/02/2009 | EP2094279A2 Methods and compositions for treating influenza |
| 09/02/2009 | EP2094278A1 Use of lipid containing particles comprising quillaja saponins for the treatment of cancer |
| 09/02/2009 | EP2094247A2 Stable polypeptide formulations |
| 09/02/2009 | EP1601770B1 Streptococcus pyogenes antigens |
| 09/02/2009 | EP1601766B1 Peptides capable of inhibiting dimerisation of c-Jun |
| 09/02/2009 | EP1557466B1 Tumor antigen protein and utilization thereof |
| 09/02/2009 | EP1523372B1 Ghrelin-carrier conjugates |
| 09/02/2009 | EP1466925B1 Antibodies against fibroblast growth factor 23 |
| 09/02/2009 | EP1448587B1 Noonan syndrome gene |
| 09/02/2009 | EP1317479B1 Methods and compositions for diseases associated with amyloidosis |
| 09/02/2009 | EP1282443B1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 09/02/2009 | EP1005368B1 Use of nucleic acids containing unmethylated CpG dinucleotide in combination with alum as adjuvants |
| 09/02/2009 | EP0892643B2 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 09/02/2009 | CN101522219A Methods and compositions with reduced opalescence |
| 09/02/2009 | CN101522218A Vaccine comprising an oil in water emulsion adjuvant |
| 09/02/2009 | CN101522217A Manufacture of booster vaccines having reduced antigen doses |
| 09/02/2009 | CN101522216A Attenuated polio viruses |
| 09/02/2009 | CN101522215A Vaccines against chlamydial infection |
| 09/02/2009 | CN101522214A Methods and compositions for needleless delivery of particles |
| 09/02/2009 | CN101522213A Method of eliciting or inducing an immune response |
| 09/02/2009 | CN101522212A Vaccines for malaria |
| 09/02/2009 | CN101522211A Methods of enhancing immune response using electroporation-assisted vaccination and boosting |
| 09/02/2009 | CN101522210A Compositions and methods of enhancing immune responses |
| 09/02/2009 | CN101522209A IPV-DPT vaccine |
| 09/02/2009 | CN101522208A Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus |
| 09/02/2009 | CN101519657A Full-length infectious cDNA clones of tick borne flavivirus |
| 09/02/2009 | CN101519448A Epididymal protease inhibitor protein monoclonal antibody and application thereof |
| 09/02/2009 | CN101519440A Intersecting protective vaccine antigen, preparation method and application thereof |
| 09/02/2009 | CN101518653A Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN101518647A Human papilloma virus preventative vaccine, construction method and application |
| 09/02/2009 | CN101518556A Polysaccharide with antitumor and immunologic adjuvant function as well as preparation method and purpose thereof |
| 09/02/2009 | CN101518549A Research and application of Mycobacterium extract |
| 09/02/2009 | CN100535108C Immunizing fish against viral infection |
| 09/02/2009 | CN100535013C Selective targeting of tumor vasculature using antibody molecules |
| 09/02/2009 | CN100534529C Ordered molecular presentation of antigens, method of preparation and use |
| 09/02/2009 | CN100534436C Polynucleotide therapy |
| 09/02/2009 | CN100534419C Colloidal suspension of nanoparticles based on am amphiphilic copolymer |
| 09/01/2009 | US7584059 Inhibition of immune complex formation |
| 09/01/2009 | US7582736 Prostate cancer specific internalizing human antibodies |
| 09/01/2009 | US7582735 use of peptides derived from IgE sequences for allergic desensitization; culturing |
| 09/01/2009 | US7582733 Modified immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy |
| 09/01/2009 | US7582731 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 09/01/2009 | US7582730 an iron-regulated protein found in Neisseria gonorrhoeae or Neisseria meningitidis outer membranes; immunizing a host against gonococcal and meningococcal diseases, such as gonorrhea, meningitis |
| 09/01/2009 | US7582726 cancer therapy utilizing novel vascular endothelial cell growth factor receptor antagonists; immunoglobulin like domain from kinase domain receptor; nucleic acid encoding prolactin receptor antagonizing domain, a VEGF ligand and a cytokine; cell based assay; |
| 09/01/2009 | US7582613 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 09/01/2009 | US7582603 Treatment of gastrointestinal inflammation by administering a peptide antagonist of tight junction opening that binds to the zonula occludens receptor, yet does not physiologically modulate the opening of mammalian tight junctions; celiac disease, inflammatory bowel disease |
| 09/01/2009 | US7582459 Process for producing a capsular polysaccharide for use in conjugate vaccines |
| 09/01/2009 | US7582450 Homogeneous preparations of IL-29 produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity |
| 09/01/2009 | US7582449 Culturing a host cell that includes a recombinant expression vector, wherein the recombinant expression vector includes a nucleic acid sequence encoding a polypeptide elicits an immune response; penumonia treatment |
| 09/01/2009 | US7582448 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 09/01/2009 | US7582445 Anti-interferon-α antibodies |
| 09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
| 09/01/2009 | US7582437 Adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
| 09/01/2009 | US7582416 Ligand for G-protein coupled receptor FPRL2 and uses thereof |
| 09/01/2009 | US7582305 Method for suppressing diarrhea in pigs, wherein a composition comprising killed bacteria of Enterococcus faecalis EC-12 (FERM ABP-10284) as an active ingredient is orally administered to pigs; efficiency |
| 09/01/2009 | US7582304 Immunizing an animal against Lyme disease by administering composition of at least two OspC polypeptides from Lyme Disease causing Borrelia comprising unlipidated and lipidated OspC polypeptides |
| 09/01/2009 | US7582303 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand |
| 09/01/2009 | US7582302 Needle-free administration of FeLV vaccines |
| 09/01/2009 | US7582301 Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides |
| 09/01/2009 | US7582300 Modulation of gamma delta T cells to regulate airway hyperresponsiveness |
| 09/01/2009 | US7582299 Cripto-specific antibodies |
| 09/01/2009 | US7582298 High affinity antibodies to human IL-6 receptor |
| 09/01/2009 | US7582297 Methods of treating respiratory conditions |
| 09/01/2009 | US7582296 Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof |
| 09/01/2009 | US7582295 Glycoprotein receptor complex; cancer therapy |
| 09/01/2009 | US7582294 Medicament for treating prostate diseases |
| 09/01/2009 | US7582293 Anti-PRO6308 antibodies |
| 09/01/2009 | US7582290 Use in suicide gene therapy of cancer cells and producing immunotoxins; infecting the cell with an adenovirus produced by a packaging cell line, where an adenoviral vector of a promoter is linked to a nucleic acid encoding the A subunit of diphtheria toxin A or Pseudomonas Exotoxin A, mutated EF-2 gene |
| 09/01/2009 | US7582289 administering to proliferating cells in a mammal having a Ras-activated pathway a viruse selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus virus under conditions which result in lysis of neoplasmic cell |
| 09/01/2009 | US7582288 Methods of targeting multiple cytokines |
| 09/01/2009 | CA2327434C Dna immunization against chlamydia infection |
| 09/01/2009 | CA2308216C Use of non-immunosuppressive compounds for promoting nerve regeneration |
| 09/01/2009 | CA2158651C Multicomponent clostridial vaccines using saponin adjuvants |
| 08/27/2009 | WO2009105729A2 Immunogenic influenza composition |
| 08/27/2009 | WO2009105681A1 Neutralization of staphylococcal and streptococcal toxins |
| 08/27/2009 | WO2009105673A2 Tumor therapy with replication competent sindbis viral vectors |
| 08/27/2009 | WO2009105557A1 Use of therapeutic peptides for the treatment and prevention of cancer |
| 08/27/2009 | WO2009105534A2 Ophthalmic nsaids as adjuvants |
| 08/27/2009 | WO2009105355A2 A novel neospora caninum vaccine |